RAPID MICRO BIOSYSTEMS, INC. Quarterly Costs and Expenses in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Rapid Micro Biosystems, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2020 to Q2 2024.
  • Rapid Micro Biosystems, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $20M, a 0.3% decline year-over-year.
  • Rapid Micro Biosystems, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $79M, a 5.07% decline year-over-year.
  • Rapid Micro Biosystems, Inc. annual Costs and Expenses for 2023 was $79.1M, a 1.58% decline from 2022.
  • Rapid Micro Biosystems, Inc. annual Costs and Expenses for 2022 was $80.4M, a 14% increase from 2021.
  • Rapid Micro Biosystems, Inc. annual Costs and Expenses for 2021 was $70.5M, a 51.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $79M $20M -$60K -0.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $79.1M $19.9M -$23K -0.12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $79.1M $18.5M -$3.11M -14.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $82.2M $20.6M -$1.03M -4.77% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $83.2M $20.1M +$2.12M +11.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $81.1M $19.9M +$748K +3.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $80.4M $21.6M +$1.87M +9.46% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $78.5M $21.6M +$2.6M +13.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $75.9M $17.9M +$942K +5.54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $74.9M $19.2M +$4.47M +30.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $70.5M $19.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $19M +$6.2M +48.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $17M +$8.39M +97.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $14.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $12.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $8.61M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.